Todd Vogel
Vascular Surgery · Columbia, MONPI 1235215054
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Endologix LLC accounts for 73.0% of it on its own, with 24 other manufacturers making up the rest.
Across 304 payments — averaging $172.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$38K
- Medtronic$7K
- W. L. Gore & Associates, Inc.$4K
- Johnson & Johnson$796
- Veryan Medical Incorporated$619
- Silk Road Medical, Inc.$618
- plus $2K from 19 others
Across 14 payments — averaging $11,845 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endologix LLC$100K
- Veryan Medical Incorporated$65K
What the payments were for
- Consulting fees$28,85055%
- Travel & lodging$7,03213%
- Food & beverage$16,55732%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 88 | $38,256 |
| Medtronic(3 entities) | 92 | $6,539 |
| W. L. Gore & Associates, Inc. | 42 | $3,824 |
| Johnson & Johnson | 30 | $796 |
| Veryan Medical Incorporated | 4 | $619 |
| Silk Road Medical, Inc. | 5 | $618 |
| Avinger Inc. | 7 | $400 |
| Bolton Medical Inc | 3 | $291 |
| Philips North America LLC | 3 | $144 |
| Angiodynamics, Inc. | 5 | $141 |
| Lemaitre Vascular, Inc. | 2 | $106 |
| Shockwave Medical, Inc | 2 | $104 |
| Surmodics, Inc. | 2 | $92 |
| Abbott | 4 | $87 |
| Baxter Healthcare | 2 | $68 |
| Cook Medical LLC | 3 | $61 |
| Cvrx, Inc. | 1 | $59 |
| Boston Scientific | 2 | $58 |
| Amgen | 1 | $46 |
| Acist Medical Systems, Inc. | 1 | $34 |
| Livanova USA, Inc. | 1 | $24 |
| Cardiovascular Systems Inc. | 1 | $22 |
| Asahi Intecc USA, Inc. | 1 | $20 |
| Bard Access Systems, Inc. | 1 | $19 |
| Haemonetics Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX2 Bifurcated Endograft System$15,955
- Alto Abdominal Stent Graft System$9,663
- ENDOCROSS Device$3,433
- Torus Stent Graft System$3,433
- IN.PACT Admiral$2,113
- ENDURANT IIS$1,564
- Ovation$1,253
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,198
- AFX$1,148
- ENROUTE Transcarotid Neuroprotection System$676
- GORE VIABAHN VBX Balloon Expandable Endo$669
- Endurant$668
- BioMimics 3D Vascular Stent System$619
- ENROUTE Transcarotid Stent$513
- GORE TAG Thoracic Branch Endoprosthesis$447
- Ovation iX Iliac Stent Graft$389
- GORE TAG Thoracic Endoprosthesis$228
- TREO ABDOMINAL STENT-GRAFT SYSTEM$217
- PANTHERIS$213
- Aptus Heli-FX$196
How this compares
$52,439 in reported general payments places this provider in the 85th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 31 | $8,617 |
| ClopidogrelClopidogrel Bisulfate | 40 | $327 |
| Prasugrel Hcl | 11 | $244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $796 | $8,61731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 92 vascular surgery providers in Missouri.
Other vascular surgery in Columbia
- Jonathan BathColumbia$76K
- Walter NicholsColumbia$56K
- Sepehr KarimiColumbia$21K
- Kaitlyn RountreeColumbia$20K
- Uttara NagColumbia$7K
- Steven CheungColumbia$6K
- Erica SalinasColumbia$5K
- Jeffrey JimSaint Louis$1.2M
- Karl StarkNorth Kansas City$223K
- Brian PetersonSaint Louis$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.